THC Biomed Intl Ltd.
THCBF
$0.00
$0.000.00%
OTC PK
| 04/30/2023 | 01/31/2023 | 10/31/2022 | 07/31/2022 | 04/30/2022 | |
|---|---|---|---|---|---|
| Revenue | -27.09% | 27.77% | -35.28% | -7.53% | -56.13% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -27.09% | 27.77% | -35.28% | -7.53% | -56.13% |
| Cost of Revenue | 1.89% | -33.56% | 219.93% | -1.08% | -50.87% |
| Gross Profit | -72.56% | 62.72% | -75.98% | -7.34% | 30.51% |
| SG&A Expenses | 8.42% | 3.42% | -40.12% | -12.66% | -59.81% |
| Depreciation & Amortization | -21.93% | -14.72% | -8.81% | -5.91% | -6.64% |
| Other Operating Expenses | -- | -- | -- | -96.40% | -25.81% |
| Total Operating Expenses | -1.35% | -24.97% | 5.29% | -5.64% | -49.19% |
| Operating Income | -15.44% | 40.30% | -985.13% | 4.71% | 43.34% |
| Income Before Tax | -567.15% | 39.73% | -1,351.76% | 5.37% | 90.12% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -567.15% | 39.73% | -1,351.76% | 5.37% | 90.12% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -567.15% | 39.73% | -1,351.76% | 5.37% | 90.12% |
| EBIT | -15.44% | 40.30% | -985.13% | 4.71% | 43.34% |
| EBITDA | -1.63% | 44.91% | -162.88% | 22.49% | 37.33% |
| EPS Basic | -600.00% | 40.00% | -1,600.00% | 2.90% | 90.63% |
| Normalized Basic EPS | -18.18% | 39.13% | -1,000.00% | 0.00% | 45.00% |
| EPS Diluted | -600.00% | 40.00% | -1,600.00% | 2.90% | 90.63% |
| Normalized Diluted EPS | -18.18% | 39.13% | -1,000.00% | 0.00% | 45.00% |
| Average Basic Shares Outstanding | 0.00% | 0.03% | 0.06% | -3.02% | 0.25% |
| Average Diluted Shares Outstanding | 0.00% | 0.03% | 0.06% | -3.02% | 0.25% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |